Eyenovia Inc (EYEN) Beta Value: Understanding the Market Risk

The 36-month beta value for EYEN is also noteworthy at 1.73. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

The public float for EYEN is 66.11M, and at present, short sellers hold a 4.58% of that float. The average trading volume of EYEN on September 05, 2024 was 1.64M shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

EYEN) stock’s latest price update

Eyenovia Inc (NASDAQ: EYEN)’s stock price has plunge by 0.82relation to previous closing price of 0.54. Nevertheless, the company has seen a 5.25% surge in its stock price over the last five trading sessions. globenewswire.com reported 2024-09-05 that Eyenovia is planning for a U.S. launch for Clobetasol in late September 2024 Eyenovia is planning for a U.S. launch for Clobetasol in late September 2024

EYEN’s Market Performance

EYEN’s stock has risen by 5.25% in the past week, with a monthly drop of -41.61% and a quarterly drop of -29.40%. The volatility ratio for the week is 11.65% while the volatility levels for the last 30 days are 14.95% for Eyenovia Inc The simple moving average for the last 20 days is -20.03% for EYEN stock, with a simple moving average of -54.69% for the last 200 days.

Analysts’ Opinion of EYEN

Many brokerage firms have already submitted their reports for EYEN stocks, with Northland Capital repeating the rating for EYEN by listing it as a “Outperform.” The predicted price for EYEN in the upcoming period, according to Northland Capital is $10 based on the research report published on March 01, 2021 of the previous year 2021.

EYEN Trading at -39.47% from the 50-Day Moving Average

After a stumble in the market that brought EYEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.85% of loss for the given period.

Volatility was left at 14.95%, however, over the last 30 days, the volatility rate increased by 11.65%, as shares sank -42.20% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -16.42% lower at present.

During the last 5 trading sessions, EYEN rose by +5.19%, which changed the moving average for the period of 200-days by -57.88% in comparison to the 20-day moving average, which settled at $0.6599. In addition, Eyenovia Inc saw -73.87% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at EYEN starting from Rowe Michael M, who purchase 27,071 shares at the price of $0.52 back on Aug 28 ’24. After this action, Rowe Michael M now owns 109,998 shares of Eyenovia Inc, valued at $14,077 using the latest closing price.

Rowe Michael M, the Chief Executive Officer of Eyenovia Inc, purchase 50,000 shares at $0.57 during a trade that took place back on Aug 26 ’24, which means that Rowe Michael M is holding 82,927 shares at $28,500 based on the most recent closing price.

Stock Fundamentals for EYEN

Current profitability levels for the company are sitting at:

  • -989.57 for the present operating margin
  • -43.64 for the gross margin

The net margin for Eyenovia Inc stands at -1187.13. The total capital return value is set at -9.88. Equity return is now at value -914.66, with -154.24 for asset returns.

Based on Eyenovia Inc (EYEN), the company’s capital structure generated 1.19 points at debt to capital in total, while cash flow to debt ratio is standing at -2.06. The debt to equity ratio resting at -6.21. The interest coverage ratio of the stock is -22.95.

Currently, EBITDA for the company is -24.62 million with net debt to EBITDA at -0.44. When we switch over and look at the enterprise to sales, we see a ratio of 1747.18. The receivables turnover for the company is 0.07for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.43.

Conclusion

In summary, Eyenovia Inc (EYEN) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts